92 related articles for article (PubMed ID: 36503897)
21.
Kansu B; Gardner J; Price-Tate R; Murch O; Murray A
J Obstet Gynaecol; 2021 Aug; 41(6):962-965. PubMed ID: 33228436
[TBL] [Abstract][Full Text] [Related]
22. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.
Buis CC; van Leeuwen FE; Mooij TM; Burger CW;
Hum Reprod; 2013 Dec; 28(12):3358-69. PubMed ID: 24014607
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.
Greene MH; Piedmonte M; Alberts D; Gail M; Hensley M; Miner Z; Mai PL; Loud J; Rodriguez G; Basil J; Boggess J; Schwartz PE; Kelley JL; Wakeley KE; Minasian L; Skates S
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):594-604. PubMed ID: 18349277
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
Cham S; Chen L; St Clair CM; Hou JY; Tergas AI; Melamed A; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2019 Jun; 220(6):571.e1-571.e8. PubMed ID: 30771346
[TBL] [Abstract][Full Text] [Related]
26. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
27. Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
Gafni A; Dite GS; Spaeth Tuff E; Allman R; Hopper JL
PLoS One; 2021; 16(9):e0251469. PubMed ID: 34525106
[TBL] [Abstract][Full Text] [Related]
28. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
[TBL] [Abstract][Full Text] [Related]
29. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study.
Jin G; Lv J; Yang M; Wang M; Zhu M; Wang T; Yan C; Yu C; Ding Y; Li G; Ren C; Ni J; Zhang R; Guo Y; Bian Z; Zheng Y; Zhang N; Jiang Y; Chen J; Wang Y; Xu D; Zheng H; Yang L; Chen Y; Walters R; Millwood IY; Dai J; Ma H; Chen K; Chen Z; Hu Z; Wei Q; Shen H; Li L
Lancet Oncol; 2020 Oct; 21(10):1378-1386. PubMed ID: 33002439
[TBL] [Abstract][Full Text] [Related]
30. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
[TBL] [Abstract][Full Text] [Related]
31. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.
Gates MA; Tworoger SS; Hecht JL; De Vivo I; Rosner B; Hankinson SE
Int J Cancer; 2007 Nov; 121(10):2225-32. PubMed ID: 17471564
[TBL] [Abstract][Full Text] [Related]
32. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
[TBL] [Abstract][Full Text] [Related]
33. Neural network-based integration of polygenic and clinical information: development and validation of a prediction model for 10-year risk of major adverse cardiac events in the UK Biobank cohort.
Steinfeldt J; Buergel T; Loock L; Kittner P; Ruyoga G; Zu Belzen JU; Sasse S; Strangalies H; Christmann L; Hollmann N; Wolf B; Ference B; Deanfield J; Landmesser U; Eils R
Lancet Digit Health; 2022 Feb; 4(2):e84-e94. PubMed ID: 35090679
[TBL] [Abstract][Full Text] [Related]
34. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.
Gornjec A; Merlo S; Novakovic S; Stegel V; Gazic B; Perhavec A; Blatnik A; Krajc M
Radiol Oncol; 2020 May; 54(2):180-186. PubMed ID: 32463390
[TBL] [Abstract][Full Text] [Related]
36. Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
Rutter JL; Wacholder S; Chetrit A; Lubin F; Menczer J; Ebbers S; Tucker MA; Struewing JP; Hartge P
J Natl Cancer Inst; 2003 Jul; 95(14):1072-8. PubMed ID: 12865453
[TBL] [Abstract][Full Text] [Related]
37. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
Antoniou AC; Cunningham AP; Peto J; Evans DG; Lalloo F; Narod SA; Risch HA; Eyfjord JE; Hopper JL; Southey MC; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tryggvadottir L; Syrjakoski K; Kallioniemi OP; Eerola H; Nevanlinna H; Pharoah PD; Easton DF
Br J Cancer; 2008 Apr; 98(8):1457-66. PubMed ID: 18349832
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
Ozanne EM; Howe R; Mallinson D; Esserman L; Van't Veer LJ; Kaplan CP
J Genet Couns; 2019 Jun; 28(3):507-515. PubMed ID: 30663827
[TBL] [Abstract][Full Text] [Related]
39. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.
Sutcliffe S; Pharoah PD; Easton DF; Ponder BA
Int J Cancer; 2000 Jul; 87(1):110-7. PubMed ID: 10861460
[TBL] [Abstract][Full Text] [Related]
40. A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus.
Chen HF; Chang YH; Ko MC; Li CY
Gynecol Oncol; 2014 Sep; 134(3):576-80. PubMed ID: 25014539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
